Search Results - "YEI-MEI PENG"

Refine Results
  1. 1

    Breast Tissue Accumulation of Retinamides in a Randomized Short-term Study of Fenretinide by SABICHI, Anita L, MODIANO, Manual R, LEE, J. Jack, PENG, Yei-Mei, XU, Ming-Jing, VILLAR, Hugo, DALTON, William S, LIPPMAN, Scott M

    Published in Clinical cancer research (01-07-2003)
    “…Purpose: The synthetic retinoid N -(4-hydroxyphenyl)retinamide [4-HPR (or fenretinide)] has preclinical and clinical preventive activity in breast…”
    Get full text
    Journal Article
  2. 2

    Concentrations and plasma-tissue-diet relationships of carotenoids, retinoids, and tocopherols in humans by Peng, Y M, Peng, Y S, Lin, Y, Moon, T, Roe, D J, Ritenbaugh, C

    Published in Nutrition and cancer (1995)
    “…Micronutrients, such as beta-carotene and vitamins A and E, are potential chemopreventive agents; however, their concentrations in human target tissues are…”
    Get more information
    Journal Article
  3. 3

    Importance of the form of topical vitamin E for prevention of photocarcinogenesis by Gensler, H L, Aickin, M, Peng, Y M, Xu, M

    Published in Nutrition and cancer (1996)
    “…With increasing solar ultraviolet (UV)-B radiation reaching the Earth's surface and the incidence of skin cancer rising steadily, there is an ever-increasing…”
    Get more information
    Journal Article
  4. 4

    Disposition and metabolism of topically administered alpha-tocopherol acetate: a common ingredient of commercially available sunscreens and cosmetics by Alberts, D S, Goldman, R, Xu, M J, Dorr, R T, Quinn, J, Welch, K, Guillen-Rodriguez, J, Aickin, M, Peng, Y M, Loescher, L, Gensler, H

    Published in Nutrition and cancer (1996)
    “…Skin cancers are a serious health problem in the United States. One common method of skin cancer primary prevention is use of sunscreens. Research has been…”
    Get more information
    Journal Article
  5. 5

    Exhaled ethane and antioxidant vitamin supplements in active smokers by Do, B K, Garewal, H S, Clements, Jr, N C, Peng, Y M, Habib, M P

    Published in Chest (01-07-1996)
    “…To determine the effect of nutritional agents on lipid peroxidation, 10 smokers were given 6 mg beta carotene, 200 IU vitamin E, and 250 mg vitamin C 4 times…”
    Get more information
    Journal Article
  6. 6

    Carotenoids, tocopherols, and retinoids in human buccal mucosal cells: intra- and interindividual variability and storage stability by Peng, YS, Peng, YM, McGee, DL, Alberts, DS

    Published in The American journal of clinical nutrition (01-03-1994)
    “…The baseline, intra-, and interindividual variability as well as storage stability of carotenoids, tocopherols, and retinoids in human buccal mucosal cells…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration by ALBERTS, D. S, SURWIT, E. A, YEI-MEI PENG, RIVEST, R, GRAHAM, V, MCDONALD, L, ROE, D

    Published in Cancer research (Chicago, Ill.) (15-10-1988)
    “…On the basis of its high degree of cytotoxicity against fresh human ovarian cancers and its relative lack of vesicant activity, mitoxantrone administered by…”
    Get full text
    Journal Article
  9. 9

    Chemoprevention of Human Actinic Keratoses by Topical 2-(Difluoromethyl)-dl-ornithine by ALBERTS, David S, DORR, Robert T, SALASCHE, Stuart, ROE, Denise J, BOWDEN, G. Timothy, EINSPAHR, Janine G, AICKIN, Mikel, SABODA, Kathylynn, MIN JIAN XU, PENG, Yei-Mei, GOLDMAN, Rayna, FOOTE, Janet A, WARNEKE, James A

    “…α-2-(Difluoromethyl)-dl-ornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase, has been shown to suppress skin carcinogenesis in murine models…”
    Get full text
    Journal Article
  10. 10

    Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial by STRUCK, R. F, ALBERTS, D. S, HORNE, K, PHILLIPS, J. G, YEI-MEI PENG, ROE, D. J

    Published in Cancer research (Chicago, Ill.) (15-05-1987)
    “…Since cyclophosphamide is used by both oral and i.v. routes in the treatment of hematological and solid malignancies, we designed a randomized, crossover…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetics of N-4-hydroxyphenyl-retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients by Peng, Y M, Dalton, W S, Alberts, D S, Xu, M J, Lim, H, Meyskens, Jr, F L

    Published in International journal of cancer (15-01-1989)
    “…Concurrent with a phase-II trial of 4HPR in patients with various cancers, we studied the plasma pharmacokinetics of both 4HPR and its major metabolite 4MPR as…”
    Get more information
    Journal Article
  12. 12

    A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma by Minor, D R, Allen, R E, Alberts, D, Peng, Y M, Tardelli, G, Hutchinson, J

    Published in Cancer (01-06-1985)
    “…The pharmacokinetics of isolated limb perfusion were studied to see what melphalan concentrations were achieved and how effective the isolation was…”
    Get more information
    Journal Article
  13. 13

    Comparative molecular pharmacology in leukemic L1210 cells of the anthracene anticancer drugs mitoxantrone and bisantrene by BOWDEN, G. T, ROBERTS, R, ALBERTS, D. S, YEI-MEI PENG, GARCIA, D

    Published in Cancer research (Chicago, Ill.) (01-10-1985)
    “…1,4-Dihydroxy-5,8-bis(2-[(2-hydroxyethyl)aminoethyl]amino)-9, 10-anthracenedione (mitoxantrone) and 9,10-anthracenedicarboxaldehyde…”
    Get full text
    Journal Article
  14. 14

    Disposition of mitoxantrone in cancer patients by ALBERTS, D. S, YEI-MEI PENG, LEIGH, S, DAVIS, T. P, WOODWARD, D. L

    Published in Cancer research (Chicago, Ill.) (01-04-1985)
    “…We have used a highly sensitive high-performance liquid chromatographic assay to evaluate the pharmacokinetics and tissue disposition of mitoxantrone, an…”
    Get full text
    Journal Article
  15. 15

    Evidence for persistence of mitoxantrone within the peritoneal cavity following intraperitoneal delivery by Markman, M, Alberts, D, Rubin, S, Hakes, T, Lewis, Jr, J L, Reichman, B, Jones, W, Curtin, J, Barakat, R, Brodar, F

    Published in Gynecologic oncology (01-02-1993)
    “…In clinical trials examining the intraperitoneal (ip) administration of mitoxantrone as therapy of platinum-refractory small-volume residual ovarian cancer,…”
    Get more information
    Journal Article
  16. 16

    13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon-α in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial by Weiss, Geoffrey R., Liu, P.Y., Alberts, David S., Peng, Yei-Mei, Fisher, Emily, Xu, Min Jian, Scudder, Sidney A., Baker, Laurence H., Moore, Dennis F., Lippman, Scott M.

    Published in Gynecologic oncology (01-12-1998)
    “…Purpose.Preclinical and clinical data support the study of retinoids and interferon-α (IFN-α) in advanced squamous cell carcinoma of the uterine cervix (SCC)…”
    Get full text
    Journal Article
  17. 17

    Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients by BUZAID, A. C, ALBERTS, D. S, EINSPAHR, J, MOSLEY, K, YEI-MEI PENG, TUTSCH, K, SPEARS, C. P, GAREWAL, H. S

    “…Dipyridamole (DP) has previously been studied both in vitro and in vivo in combination with various anti-metabolites, including methotrexate and 5-fluorouracil…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Influence of serum and tissue micronutrient levels on the regression of untreated cervical intraepithelial neoplasia 2 and 3 by McHale, Michael T, Berman, Michael L, Keefe, Kristin A, Schell, Michael J, Peng, Yei-Mei, Monk, Bradley J

    Published in Journal of lower genital tract disease (01-10-2002)
    “…OBJECTIVE.: To determine the influence of micronutrient levels on the regression of untreated cervical intraepithelial neoplasia (CIN). MATERIALS AND METHODS.:…”
    Get full text
    Journal Article
  20. 20

    A phase I trial of AUC-directed carboplatin with infusional doxorubicin and ifosfamide plus G-CSF in patients with advanced gynecologic malignancies by LOPEZ, Ana Maria, KETCHUM, Marsha, NICHOLS, Heather, XU, Min-Jian, PENG, Yei-Mei, DORR, Robert, ALBERTS, David S

    “…The effect of the addition of G-CSF to carboplatin, ifosfamide and doxorubicin (CIA) at the maximally tolerated dose (MTD) was studied in a phase I clinical…”
    Get full text
    Journal Article